Products

Wonderstand

AI-native

Never lose a buyer to a slow reply. AI assistant built for real estate agents.

wonderstand.ai Industry Software / Real Estate

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$199/mo
Higher than 92% of peersNiche median $25/mo
Creators
Jide Lambo
@jidelambo· 1,273 followers
Launched
22mo ago
2025-02-03 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Your AI Companions, Personalized & Inspired by Legends

    Feb 3, 2025 · 22mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2025-01-20

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Wonderstand
$199/mo

Trial: None · 1 paid tier ($199) · Observed 2026-11-07 · Pricing page

Entry price $199/mo, Higher than 92% of peers; “Real Estate” median is $25/mo.View pricing benchmark

Pages & changes

Tracked since 2025-02-03

Key pages

Weekly snapshots
wonderstand.ai/ Snapshot 2026-11-08

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Wonderstand cost?
Wonderstand: $199/mo. Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Wonderstand get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Wonderstand and what platforms does it support?
Wonderstand is catalogued under Real Estate: Never lose a buyer to a slow reply. AI assistant built for real estate agents.. Supported platforms: Web.

Related products in this category

Industry Software / Real Estate

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.